It's my passion to contribute to new knowledge via Scientific Research.
I'm a student enrolled in the University of Pittsburgh's 8-year BS/MD program at the School of Medicine and Dietrich School of Arts & Sciences, with an expected graduation in May 2030.
Throughout my academic career, I've been fortunate to receive numerous honors and awards, including the 2023 Academy Award from the American Academy of Neurological Surgeons and a $15,000 prize as the winner of the University of Pittsburgh Randall Family Big Idea Competition. I've also been recognized as a Regeneron Science Talent Search Top 300 Scholar and received the National Merit Scholarship.
My passion for research and healthcare has led me to engage in various projects and experiences. I'm currently a researcher at the Cerebral Aneurysms Research Lab within the Department of Neurological Surgery at UPMC, where I've made significant contributions to the field. I'm also the Founder and CEO of ScOAPe, a startup company focused on nasal endoscope cleaning attachment innovation.
In addition to my research endeavors, I've gained hands-on experience as a Medical Assistant at Dr. Nesochi, LLC Primary Care Office. I also serve as an EMT at the Saddle Brook Volunteer Ambulance Corps.
My commitment to making a difference extends beyond the lab and clinic. I've volunteered as a math tutor at Common Denominator, supporting underserved middle school students in NY City. I've also actively participated in political campaigns, including my role as a campaign volunteer for Josh Gottheimer for the U.S. House of Representatives.
I'm passionate about research, innovation, and contributing to improving healthcare. I look forward to continued growth and collaboration in these fields as I progress through my academic and professional journey. Please feel free to contact me to explore potential opportunities -or- discuss shared interests.
Parkinson’s Disease (PD) is the second most common neurodegenerative disease, and it plagues millions of people worldwide. PD presents with the loss of dopaminergic neurons, associated with increased oxidative stress due to the formation of reactive oxygen species (ROS). The formation of ROS is facilitated by Lewy bodies and α-synuclein neurofibrillary tangles, which lead to PD progression. In healthy neurons, oxidative stress is countered by cellular antioxidant defense systems, a prominent one being glutathione (GSH), however in PD, GSH levels are typically diminished. A precursor for GSH is the amino acid glutamine, which is converted intracellularly from glutamine to glutamate to GSH. The carrier for glutamine uptake is a transport membrane protein, named ASCT2, and this protein regulates glutamine levels in the cell. In various forms of cancer, inhibition of ASCT2 has led to oxidative stress-mediated apoptosis.
This research looked to elucidate the role ASCT2 can play in PD progression by using α-synuclein transfected SH-SY5Y neurons as an in vitro model of PD. V-9302 is a competitive inhibitor of ASCT2 and was used to diminish ASCT2 transport and glutamine uptake to examine the in vitro hallmarks of PD progression. To assess PD progression, cell viability, cell proliferation, α-synuclein levels and ROS were measured. To assess the significance of ASCT2 in the glutamine to GSH conversion process, glutamine uptake, glutamate levels, and GSH levels were measured. Data suggests that increasing V-9302 concentrations (decreased ASCT2 activity) led to lower cell viability and proliferation and higher ROS levels and α-synuclein levels. Also, increasing V-9302 concentrations led to a decrease in intracellular glutamine, glutamate, and GSH levels. In addition, a power regression model was generated for each of glutamine, glutamate, and GSH vs α-synuclein to test the biomarker potential of each of these molecules for PD progression in this model, and it was found that each of these molecules fit the regression model extraordinarily. This further supports the role of ASCT2 in altering PD progression.
These results suggest that ASCT2 has the potential to play a significant role in PD progression. Results suggest that inhibition of ASCT2 lead to the heightened hallmarks of PD progression. Future research could examine the potentially therapeutic effects of upregulating ASCT2 on PD progression.
For the most up-to-date information on my recent experiences, kindly visit my LinkedIn profile
Major in Biological Sciences
Cumulative GPA: 4.00/4.00
High School Graduated in June 2022
GPA: 3.99/4.00
SAT: 1570/1600 (Evidence-Based Reading and Writing: 770; Math: 800)
SAT II: Biology: 800/800
SAT II: Math: 800/800
ACT: Superscore 36/36; Composite: 35/36 (English: 35; Reading: 35; Math: 35; Science: 36)
AP Calculus BC 5; AP Chemistry 5; AP Biology 5; AP Psychology 5; AP Statistics 5
High Honor Roll: 2018 - 2022
Kamil W Nowicki, Aditya Mittal, Michael D’Angelo, Catherine Cao, Rohit Mantena, Rachel Jacobs, Joseph Hudson, Michael McDowell, Robert M Friedlander. Targeting CXCR1 Rather Than CXCR2 Receptor in CXCL7-CXCR1/2 Pathway Prevents Cerebral Aneurysm Formation. Presented at: AANS. 2023. Los Angeles, CA. Podium Lecture Presentation.
Kamil W Nowicki, Aditya Mittal, Michael M McDowell, Robert Dembinski, Ahmed Habib, Catherine Cao, Rohit Mantena, Michael J. Lang, Pascal O. Zinn, Bradley A. Gross, Robert M Friedlander. A Whole Blood Mini-Proteomic Assay to Detect Cerebral Aneurysm Formation and Progression. Presented at: AANS. 2023. Los Angeles, CA. Poster Presentation
Aditya Mittal, Kamil W Nowicki, Rohit Mantena, Catherine Cao, Michael J. Lang, Bradley A. Gross, Robert M Friedlander. A Novel Murine Cerebral Vasospasm Model Reveals Inflammatory Temporal Dynamics of Vasospasm. Presented at: AANS. 2023. Los Angeles, CA. Poster Presentation.
Jason Lofters, Marwa Elsheikh, Rohit Mantena, Minaxi Jhawer. An approach to the management of recurrent metastatic squamous cell carcinoma of the anus: A case report. Journal of Case Reports and Images in Oncology, 2023..